Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Case report

Penile metastasis from primary cholangiocarcinoma: the first case report

Authors: Antonio Luigi Pastore, Giovanni Palleschi, Giorgia Manfredonia, Piero Maceroni, Domenico Alvaro, Domenico De Santis, Simone Ferretti, Natale Porta, Claudio Di Cristofano, Carlo Della Rocca, Andrea Fuschi, Yazan Al Salhi, Cristina Maggioni, Davide Moschese, Vincenzo Petrozza, Antonio Carbone

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Metastatic penile carcinoma derived from cholangiocarcinoma (CCA) has not been previously reported in the literature. Common metastatic sites for CCA include the regional lymph nodes and adjacent organs. CCAs are not highly vascularised tumours, making hematogenous metastases uncommon. Hematogenous CCA metastases commonly occur at distant organs such as the lungs, adrenal glands, and bones. Median survival for patients with metastatic disease is generally less than 1 year.

Case presentation

A 74-year-old Caucasian man consulted us after having undergone penile ultrasonography for pain and increased thickness at the base of the penis after self-examination. The patient presented with a history of hepatitis C-related cirrhosis and intrahepatic CCA, diagnosed 3 years previously. A biopsy of the corpora cavernosa on both sides revealed a carcinoma harbouring the same histological and immunophenotypical features as the primary hepatic lesion.

Conclusions

To date, there is no case of penile or urogenital system metastasis from CCA described in the literature. Therefore, this article represents the first case report of penile metastasis from CCA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Charbel H, Al-Kawas FH: Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep. 2011, 13 (2): 182-187. 10.1007/s11894-011-0178-8.CrossRefPubMed Charbel H, Al-Kawas FH: Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep. 2011, 13 (2): 182-187. 10.1007/s11894-011-0178-8.CrossRefPubMed
2.
go back to reference Chindaprasirt J, Sookprasert A, Sawanyawisuth K, Limpawattana P, Tiamkao S: Brain metastases from cholangiocarcinoma: a first case series in Thailand. Asian Pac J Cancer Prev. 2012, 13 (5): 1995-1997. 10.7314/APJCP.2012.13.5.1995.CrossRefPubMed Chindaprasirt J, Sookprasert A, Sawanyawisuth K, Limpawattana P, Tiamkao S: Brain metastases from cholangiocarcinoma: a first case series in Thailand. Asian Pac J Cancer Prev. 2012, 13 (5): 1995-1997. 10.7314/APJCP.2012.13.5.1995.CrossRefPubMed
4.
go back to reference Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 2005, 366 (9493): 1303-1314. 10.1016/S0140-6736(05)67530-7.CrossRefPubMed Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 2005, 366 (9493): 1303-1314. 10.1016/S0140-6736(05)67530-7.CrossRefPubMed
5.
go back to reference Kidambi T, Mahajan A, DiBardino D: Cholangiocarcinoma presenting as metastases to the cervical spine. Am J Med. 2011, 24: 1-2.CrossRef Kidambi T, Mahajan A, DiBardino D: Cholangiocarcinoma presenting as metastases to the cervical spine. Am J Med. 2011, 24: 1-2.CrossRef
6.
go back to reference Li J, Henry MR, Roberts LR: Rare distant skeletal metastasis from hilar cholangiocarinoma: report of a case. J Gastrointest Cancer. 2011, 42: 171-173. 10.1007/s12029-010-9237-x.CrossRefPubMed Li J, Henry MR, Roberts LR: Rare distant skeletal metastasis from hilar cholangiocarinoma: report of a case. J Gastrointest Cancer. 2011, 42: 171-173. 10.1007/s12029-010-9237-x.CrossRefPubMed
7.
go back to reference Park MH, Cho JS, Lee JS, Kim HK, Yoon JH: Thyroid gland metastasis arising from primary liver cholangiocarcinoma: The first case report involving surgical operation. Int J Surg Case Rep. 2012, 3: 78-81. 10.1016/j.ijscr.2011.11.001.CrossRefPubMed Park MH, Cho JS, Lee JS, Kim HK, Yoon JH: Thyroid gland metastasis arising from primary liver cholangiocarcinoma: The first case report involving surgical operation. Int J Surg Case Rep. 2012, 3: 78-81. 10.1016/j.ijscr.2011.11.001.CrossRefPubMed
8.
go back to reference Alpini G, Invernizzi P, Gaudio E, Venter J, Kopriva S, Bernuzzi F, Onori P, Franchitto A, Coufal M, Frampton G, Alvaro D, Lee SP, Marzioni M, Benedetti A, DeMorrow S: Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res. 2008, 68 (22): 9184-9193. 10.1158/0008-5472.CAN-08-2133.CrossRefPubMedPubMedCentral Alpini G, Invernizzi P, Gaudio E, Venter J, Kopriva S, Bernuzzi F, Onori P, Franchitto A, Coufal M, Frampton G, Alvaro D, Lee SP, Marzioni M, Benedetti A, DeMorrow S: Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res. 2008, 68 (22): 9184-9193. 10.1158/0008-5472.CAN-08-2133.CrossRefPubMedPubMedCentral
9.
go back to reference Onori P, Wise C, Gaudio E, Franchitto A, Francis H, Carpino G, Lee V, Lam I, Miller T, Dostal DE: Glaser ¨ Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptorInt J. Cancer. 2010, 127 (1): 43-54. Onori P, Wise C, Gaudio E, Franchitto A, Francis H, Carpino G, Lee V, Lam I, Miller T, Dostal DE: Glaser ¨ Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptorInt J. Cancer. 2010, 127 (1): 43-54.
10.
go back to reference Chaux A, Amin M, Cubilla AL, Young RH: Metastatic tumors to the penis: a report of 17 cases and review of the literature. Int J Surg Pathol. 2011, 19 (5): 597-606. 10.1177/1066896909350468.CrossRefPubMed Chaux A, Amin M, Cubilla AL, Young RH: Metastatic tumors to the penis: a report of 17 cases and review of the literature. Int J Surg Pathol. 2011, 19 (5): 597-606. 10.1177/1066896909350468.CrossRefPubMed
Metadata
Title
Penile metastasis from primary cholangiocarcinoma: the first case report
Authors
Antonio Luigi Pastore
Giovanni Palleschi
Giorgia Manfredonia
Piero Maceroni
Domenico Alvaro
Domenico De Santis
Simone Ferretti
Natale Porta
Claudio Di Cristofano
Carlo Della Rocca
Andrea Fuschi
Yazan Al Salhi
Cristina Maggioni
Davide Moschese
Vincenzo Petrozza
Antonio Carbone
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-149

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.